Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12

Journal of Clinical Investigation

Volumn 110, Issue 4, 2002, Pages 493-497

  Becher, Burkhard ^a   Durell, Brigit G ^a   Noelle, Randolph J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; PROTEIN P35; PROTEIN P40; PROTEIN SUBUNIT;

ALLERGIC ENCEPHALITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; LYMPH NODE CELL; MOUSE; MOUSE STRAIN; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; TH2 CELL;

EID: 0036677420     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215751     Document Type: Article

References (28)

1. Interleukin-12, a key cytokine in Th1-mediated autoimmune diseases
2. Interleukin-12: A cytokine at the interface of inflammation and immunity
3. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses
4. Interferon beta in multiple sclerosis: Is IL-12 suppression the key?
5. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease
6. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
7. Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 ligand
8. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy
9. Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MS
10. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
11. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans
12. Alloantigen-reactive Th1 development in IL-12-deficient mice
13. Contrasting roles of IL-12p40 and IL-12p3S in the development of hapten-induced colitis
14. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present
15. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system
16. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease
17. The critical role of IL-12 and the IL-12R beta 2 subunit in the generation of pathogenic autoreactive Th1 cells
18. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines
19. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease
20. In vivo production and function of IL-12 p40 homodimers
21. Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits
22. Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but nor from tumor necrosis factor alpha-dependent shock
23. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo
24. A protective and agonistic function of IL-12p40 in mycobacterial infection
25. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death
26. A receptor for the hererodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R
27. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis
28. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis